Studies of Breast Cancer Imaging with Radiolabeled Antibodies to Carcinoembryonic Antigen

Acta Medica Austriaca

Volumn 24, Issue 2, 1997, Pages 55-59

  Goldenberg, D M ^a   Wegener, W ^b   Line, B ^c   Seldin, D W ^d   A Nabi, H ^e   Serafini, A ^f   Barron, B ^g  

^a GARDEN STATE CANCER CENTER   (United States)

^b IMMUNOMEDICS INC   (United States)

^c ALBANY MEDICAL CENTER   (United States)

^d LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^e UNIVERSITY AT BUFFALO   (United States)

^f UNIVERSITY OF MIAMI   (United States)

^g UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Arcitumomab; Breast cancer; Carcinoembryonic antigen; CEA Scan ; Immunoscintigraphy; Mammography; Monoclonal antibodies

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; DIAGNOSTIC AGENT; MONOCLONAL ANTIBODY; TECHNETIUM COMPLEX; TECHNETIUM TC 99M ARCITUMOMAB; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST; BREAST TUMOR; CANCER STAGING; CLINICAL TRIAL; FEMALE; HUMAN; IMMUNOLOGY; LYMPH NODE METASTASIS; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PROSPECTIVE STUDY; RADIOIMMUNOASSAY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; ANTIBODIES, MONOCLONAL; BREAST; BREAST NEOPLASMS; CARCINOEMBRYONIC ANTIGEN; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; ORGANOTECHNETIUM COMPOUNDS; PROSPECTIVE STUDIES; RADIOIMMUNODETECTION; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0030630011     PISSN: 03038173     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. DeLand FH, Kim EE, Corgan RL, Casper S, Primus FJ, Spremulli E, Estes N, Goldenberg DM: Axillary lymphoscintigraphy in radioimmunodetection of carcinoembryonic antigen in breast cancer. J Nucl Med 1979;20:1243-1250.
2. Goldenberg DM, DeLand F, Kim E, Bennett S, Primus FJ, van Nagell JR, Estes N, DeSimone P, Rayburn P: Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning. N Engl J Med 1978;298:1384-1388.
3. Goldenberg DM, Kim E, DeLand FH, Bennett SJ, Primus FJ: Radioimmunodetection of cancer with radioactive antibodies to carcinoembryonic antigen. Cancer Res 1980;40:2984-2992.
4. Goldenberg DM, Larson SM: Radioimmunodetection in cancer identification. J Nucl Med 1992;33:803-814.
5. Greenstein S, Schnall MD, Newman RW, Powell CH, Torosian MH, Rosato EF. MR imaging-guided localization and biopsy of breast lesions: Initial experience. Radiology 1994;193:97-102.
6. Gulec SA, Serafini AN, Moffat FL, Francheschi D, Velez PG, Boggs J, Gargano CA, Robinson DS, Sfakianakis GN: Radioimmunoscintigraphy of breast carcinoma using technetium-99m-labeled Fab' fragment of anticarcinoembryonic antigen monoclonal antibody IMMU-4(CEA-Scan™). Diagn Oncol 1994/95;4:209-213.
7. Hughes K, Pinsky CM, Petrolli NJ, Mofat FL, Patt YZ, Hammershaimb L, Goldenberg DM: Use of carcinoembryonic antigen radioimmunodetection and computed tomography for predicting resectability of recurrent colorectal cancer. Ann Surg 1997, in press.
8. Jackman RJ, Nowels KWE, Shepard MJ, Finkelstein SL, Mazzoni FA Jr: Stereotactic large-core needle biopsy of 450 nonpalpable breast lesions with surgical correlations in lesions with cancer or atypical hyperplasia. Radiology 1994;193:91-95.
9. Lastoria S, Piccolo S, Varella P, Acampa W, Mainolfi C, Vergara E, Wang H, Muto P, Salvatore M: Comparative results of Tc-99m MIBI andTc-99m MDP scintimammography in patients with breast abnormalities. J Nucl Med 1995;36:51P(A)204.
10. 99mTc-labeled monoclonal antibody (BW431/26) reacting with carcinoembryonic antigen in breast cancer. Cancer Res 1990;50:949-954.
11. Khalkhali I, Cutrone JA, Mena ID, Diggles LE, Venegas RJ, Vargas HI, Jackson BL, Khalkhali S, Mass JF, Klein SR: Scintimammography: The complementary role of Tc-99m sestamibi prone breast imaging for the diagnosis of breast carcinoma. Radiology 1995;196:421-426.
12. Lind P, Smola MG, Lechner P, Ratschek M, Klima G, Költringer P, Steindorfer P, Eber O: The immunoscintigraphic use of Tc-99m-labeled monoclonal anti-CEA antibodies (BW 431/26) in patients with suspected primary, recurrent and metastatic breast cancer. Int J Cancer 1991;47:865-869.
13. Moffat F, Pinsky CM, Hammershaimb L, Petrelli NJ, Patt YZ, Whaley ES, Goldenberg DM: Clinical utility of external immunoscintigraphy with the IMMU-4 technetium-99m Fab' antibody fragment in patients undergoing surgery for carcinoma of the colon and rectum: Results of a pivotal, Phase III trial. J Clin Oncol 1996;14:2295-2305.
14. Nabi HA: Antibody imaging in breast cancer. Sem Nucl med 1997;27:30-39.
15. Palmedo H, Schomburg A, Grunwald F, Mallman P, Krebs D, Biersack HJ: Technetium-99m-MIBI-scintimammography for suspicious breast lesions. J Nucl Med 1996;37:626-630.
16. Parker SH, Burbank F, Jackman RJ, Aucreman CJ, Cardenosa G, Cink TM, Coscia JL Jr, Eklund GW, Evans WP III, Garver PR: Percutaneous large-core breast biopsy: A multi-instutional study. Radiology 1994;193:359-364.
17. Rosner D, Abdel-Nabi H, Panaro V, Goldenberg DM: Carcinoembryonic antigen immunoscintigraphy may reduce the number of surgical biopsies in women with non-palpable, benign breast disease detected by screening mammography. Submitted for publication.
18. Rosner D, Bedwani RN, Vane J, Baker H, Murphy GP: Noninvasive breast carcinomas. Results of a national survey by the American College of Surgeons. Ann Surg 1980;192:139-147.
19. Rosner D, Lane WW, Penetrante R: Ductal carcinoma in situ with microinvasion. A curable entity using surgery alone without need for adjuvant therapy. Cancer 1991;67:1498-1503.
20. Rosner D, Nemoto T, Dao T: Detection of asymptomatic breast cancer in the second breast by mammographic follow-up: A five year survey, in Nieburg HE (ed): Prevention and detection of cancer. New York, H. Decker, 1978, pp 1281-1285.
21. Taillefer R, Robidoux A, Lambert R, Turpin S, Lapertiere J: Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement. J Nucl Med 1995;36:1758-1765.
22. Wahl RL, Cody RL, Hutchins GD, Mudgett EE: Primary and metastatic breast carcinoma: Initial clinical evaluation with PET with radiolabelled glucose analogue 2-[F-18)-fluoro-2-deoxy-D-glucose. Radiology 1991;179:765-770.
23. Waxman A, Nagaraj N, Kovalesky N, Phillips E, Yadegar J, Silberman A, Memsic L: Detection of primary breast malignancy with Tc-99m methoxyisobutylisenitrile (MIBI) in patients with non-palpable primary malignancies. J Nucl Med 1995;36:194P(A)877.